Environmental Risk Assessment

White paper

Legal Changes to Fortify ERA of Pharmaceuticals
 

Author: Dr Angela Vogt-Eisele

The proposed EU directive on medicinal products for human use introduces significant changes to Environmental Risk Assessments (ERA). This whitepaper provides a detailed analysis of new regulatory requirements, including stricter ERA criteria, mandatory updates, and enhanced risk mitigation measures. Learn how the revised guidelines affect marketing authorisations, generic products, and compliance strategies.

Download now the white paper 'Environmental Risk Assessment – Legal Changes to Fortify ERA of Pharmaceuticals'.

We hope you find the content insightful and engaging.

White paper - Environmental Risk Assessment

Download

I agree that the FORUM Institut may contact me to inform me about events and relevant content.
I can revoke my permission at any time.